![Toshifumi Tada](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Toshifumi Tada
Corporate Officer/Principal bij MITSUBISHI CHEMICAL GROUP CORPORATION
Profiel
Toshifumi Tada is currently the Director-Asia & Europe Business Division at Mitsubishi Chemical Group Corp.
Prior to this, he served as the President, Chief Executive Officer & Director at Medicago, Inc.
Actieve functies van Toshifumi Tada
Bedrijven | Functie | Begin |
---|---|---|
MITSUBISHI CHEMICAL GROUP CORPORATION | Corporate Officer/Principal | 01-04-2024 |
Eerdere bekende functies van Toshifumi Tada
Bedrijven | Functie | Einde |
---|---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Algemeen Directeur | 01-04-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
Bedrijven in privébezit | 1 |
---|---|
Medicago, Inc.
![]() Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |